AURKB and neoplasm: As schematically represented in Figure 9 where the anticancer activities of AdoMet and its molecular targets are summarized, AdoMet was able to kill tumor cells through inhibiting DNA repair, cell cycle progression, and Aurora B kinase expression and activity, ultimately causing cell death following the activation of apoptosis and mitotic catastrophe.